Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 211

1.

A Novel Natural Influenza A H1N1 Virus Neuraminidase Inhibitory Peptide Derived from Cod Skin Hydrolysates and Its Antiviral Mechanism.

Li J, Chen Y, Yuan N, Zeng M, Zhao Y, Yu R, Liu Z, Wu H, Dong S.

Mar Drugs. 2018 Oct 10;16(10). pii: E377. doi: 10.3390/md16100377.

2.

Computational screening of known broad-spectrum antiviral small organic molecules for potential influenza HA stem inhibitors.

Mathew S, Al Thani AA, Yassine HM.

PLoS One. 2018 Sep 4;13(9):e0203148. doi: 10.1371/journal.pone.0203148. eCollection 2018.

3.

Design of peptide epitope from the neuraminidase protein of influenza A and influenza B towards short peptide vaccine development.

Sankar S, Ramamurthy M, Suganya S, Nandagopal B, Sridharan G.

Bioinformation. 2018 May 31;14(5):183-189. doi: 10.6026/97320630014183. eCollection 2018.

4.

Berberine-piperazine conjugates as potent influenza neuraminidase blocker.

Enkhtaivan G, Kim DH, Park GS, Pandurangan M, Nicholas DA, Moon SH, Kadam AA, Patel RV, Shin HS, Mistry BM.

Int J Biol Macromol. 2018 Nov;119:1204-1210. doi: 10.1016/j.ijbiomac.2018.08.047. Epub 2018 Aug 10.

PMID:
30099043
5.

Synthesis, molecular docking and biological evaluation of novel phthaloyl derivatives of 3-amino-3-aryl propionic acids as inhibitors of Trypanosoma cruzi trans-sialidase.

Kashif M, Chacón-Vargas KF, López-Cedillo JC, Nogueda-Torres B, Paz-González AD, Ramírez-Moreno E, Agusti R, Uhrig ML, Reyes-Arellano A, Peralta-Cruz J, Ashfaq M, Rivera G.

Eur J Med Chem. 2018 Aug 5;156:252-268. doi: 10.1016/j.ejmech.2018.07.005. Epub 2018 Jul 7.

PMID:
30006170
6.

[Creation of a generalized model prediction of inhibition of neuraminidase of influenza virus of various strains].

Mikurova AV, Skvortsov VS.

Biomed Khim. 2018 Jun;64(3):247-252. doi: 10.18097/PBMC20186403247. Russian.

PMID:
29964260
7.

Synthesis, in-Vitro and in Silico Studies of Azo-Based Calix[4]arenes as Antibacterial Agent and Neuraminidase Inhibitor: A New Look Into an Old Scaffold.

Ali Y, Muhamad Bunnori N, Susanti D, Muhammad Alhassan A, Abd Hamid S.

Front Chem. 2018 Jun 12;6:210. doi: 10.3389/fchem.2018.00210. eCollection 2018.

8.

In search of effective H1N1 neuraminidase inhibitor by molecular docking, antiviral evaluation and membrane interaction studies using NMR.

Malbari K, Gonsalves H, Chintakrindi A, Gohil D, Joshi M, Kothari S, Srivastava S, Chowdhary A, Kanyalkar M.

Acta Virol. 2018;62(2):179-190. doi: 10.4149/av_2018_209.

PMID:
29895159
9.

Acylguanidine derivatives of zanamivir and oseltamivir: Potential orally available prodrugs against influenza viruses.

Hsu PH, Chiu DC, Wu KL, Lee PS, Jan JT, Cheng YE, Tsai KC, Cheng TJ, Fang JM.

Eur J Med Chem. 2018 Jun 25;154:314-323. doi: 10.1016/j.ejmech.2018.05.030. Epub 2018 May 21.

PMID:
29843102
10.

Discovery of (E)-1-amino-4-phenylbut-3-en-2-ol derivatives as novel neuraminidase inhibitors.

Lu C, Yin Y, Meng F, Dun Y, Pei K, Wang C, Xu X, Wu F.

Bioorg Med Chem Lett. 2018 Jun 15;28(11):2003-2007. doi: 10.1016/j.bmcl.2018.05.002. Epub 2018 May 4.

PMID:
29748050
11.

Hyphenated 3D-QSAR statistical model-drug repurposing analysis for the identification of potent neuraminidase inhibitor.

Rohini K, Shanthi V.

Cell Biochem Biophys. 2018 Sep;76(3):357-376. doi: 10.1007/s12013-018-0844-7. Epub 2018 Apr 23.

PMID:
29687225
12.

In silico study of carvone derivatives as potential neuraminidase inhibitors.

Jusoh N, Zainal H, Abdul Hamid AA, Bunnori NM, Abd Halim KB, Abd Hamid S.

J Mol Model. 2018 Mar 15;24(4):93. doi: 10.1007/s00894-018-3619-6.

PMID:
29546582
13.

Study on the Mechanisms of Active Compounds in Traditional Chinese Medicine for the Treatment of Influenza Virus by Virtual Screening.

Ai H, Wu X, Qi M, Zhang L, Hu H, Zhao Q, Zhao J, Liu H.

Interdiscip Sci. 2018 Jun;10(2):320-328. doi: 10.1007/s12539-018-0289-0. Epub 2018 Mar 2.

PMID:
29500549
14.

Design and synthesis of constrained bicyclic molecules as candidate inhibitors of influenza A neuraminidase.

Colombo C, Podlipnik Č, Lo Presti L, Niikura M, Bennet AJ, Bernardi A.

PLoS One. 2018 Feb 28;13(2):e0193623. doi: 10.1371/journal.pone.0193623. eCollection 2018.

15.

The inhibitory performance of flavonoid cyanidin-3-sambubiocide against H274Y mutation in H1N1 influenza virus.

Kannan S, Kolandaivel P.

J Biomol Struct Dyn. 2017 Dec 20:1-15. doi: 10.1080/07391102.2017.1413422. [Epub ahead of print]

PMID:
29199545
16.

Peramivir analogues bearing hydrophilic side chains exhibit higher activities against H275Y mutant than wild-type influenza virus.

Chiu DC, Lin TC, Huang WI, Cheng TJ, Tsai KC, Fang JM.

Org Biomol Chem. 2017 Nov 29;15(46):9910-9922. doi: 10.1039/c7ob02374j.

PMID:
29159346
17.

Neuraminidase Inhibitory Activity and Constituent Characterization of Fagopyrum dibotrys.

Zhang X, Cao Y, Li J, Liu A, Liu H, Huang L.

Molecules. 2017 Nov 18;22(11). pii: E1998. doi: 10.3390/molecules22111998.

18.

Design, synthesis and biological evaluation of novel oseltamivir derivatives as potent neuraminidase inhibitors.

Wang Z, Cheng LP, Zhang XH, Pang W, Li L, Zhao JL.

Bioorg Med Chem Lett. 2017 Dec 15;27(24):5429-5435. doi: 10.1016/j.bmcl.2017.11.003. Epub 2017 Nov 4.

PMID:
29141777
19.

Inhibition activity of a traditional Chinese herbal formula Huang-Lian-Jie-Du-Tang and its major components found in its plasma profile on neuraminidase-1.

Zhou X, Li H, Shi Z, Gao S, Wei S, Li K, Wang J, Li J, Wang R, Gong M, Zhao Y, Xiao X.

Sci Rep. 2017 Nov 14;7(1):15549. doi: 10.1038/s41598-017-15733-7.

20.

Virtual screening approach to identifying influenza virus neuraminidase inhibitors using molecular docking combined with machine-learning-based scoring function.

Zhang L, Ai HX, Li SM, Qi MY, Zhao J, Zhao Q, Liu HS.

Oncotarget. 2017 Sep 15;8(47):83142-83154. doi: 10.18632/oncotarget.20915. eCollection 2017 Oct 10.

Supplemental Content

Loading ...
Support Center